How does the presence of CABG affect your radiotherapy approach for definitive management of locally advanced NSCLC with mediastinal involvement?
E.g. A patient with station 4 and 5 nodal disease and arterial grafts.
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Cedars-Sinai Medical Center
Answered on
This is a great question. The short answer is we don’t exactly know – but the longer answer would be that while CABG graft dosimetry hasn’t been explicitly defined, we can make a few reasonable extrapolations and assumptions. We know that patients with +CAD are at very high risk of cardiac events, a...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · UCLA | VA Greater Los Angeles Healthcare System
Answered on
I learned a while ago from @Dr. First Last to not push the intermediate doses around based on hypothesized limits to make ourselves feel better about a plan. We simply need to think about the normal anatomy, organ function, and its current physiological state to counsel our patients about the risk o...
Join for free or sign in to see the full answer